Did James Langevin sell Alexion Pharmaceuticals stock?

Common questions

Did James Langevin sell Alexion Pharmaceuticals stock?

Yes. James Langevin disclosed 3 sales of Alexion Pharmaceuticals (ALXN) stock between Dec 8, 2014 and Jul 9, 2021, in STOCK Act reports. Added together, the disclosed ranges come to $31K-$115K.

How big were James Langevin's Alexion Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed ranges come to $31K-$115K.

Did James Langevin make these Alexion Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does James Langevin still own Alexion Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did James Langevin report these trades?

The latest filing is dated Aug 14, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.